Literature DB >> 10866978

Flexibility of the alpha-spectrin N-terminus by EPR and fluorescence polarization.

L Cherry1, L W Fung, N Menhart.   

Abstract

The structure and flexibility of the biologically important alpha-spectrin amino terminal region was examined by the use of fluorescence and EPR spectroscopy. The region studied has been previously demonstrated to be essential for the alpha-spectrin:beta-spectrin association of the tetramerization site. Appropriate spectroscopic probe moieties were coupled to this region in a recombinant fragment of human erythroid alpha-spectrin. There was good agreement between the EPR and fluorescence techniques in most of this region. Mobility determinations indicated that a portion of the region was relatively immobilized. This is significant, since although predictive methods have indicated that this region should be alpha-helical, previous experimental evidence obtained on smaller synthetic peptides had indicated that this region was disordered. Observed rigidity appears to be incompatible with such a disordered state, and has important ramifications for the flexibility of this molecule that is so integral to its role in stabilizing erythrocyte membranes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866978      PMCID: PMC1300956          DOI: 10.1016/S0006-3495(00)76314-4

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  49 in total

1.  Properties of spin and fluorescent labels at a receptor-ligand interface.

Authors:  R Owenius; M Osterlund; M Lindgren; M Svensson; O H Olsen; E Persson; P O Freskgård; U Carlsson
Journal:  Biophys J       Date:  1999-10       Impact factor: 4.033

2.  Spin label EPR structural studies of the N-terminus of alpha-spectrin.

Authors:  L Cherry; N Menhart; L W Fung
Journal:  FEBS Lett       Date:  2000-01-28       Impact factor: 4.124

Review 3.  Genetics of the red cell membrane skeleton.

Authors:  J Palek; S Lambert
Journal:  Semin Hematol       Date:  1990-10       Impact factor: 3.851

4.  Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain. Spectrin Culoz (GGT----GTT; alpha I 40 Gly----Val) and spectrin Lyon (CTT----TTT; alpha I 43 Leu---Phe).

Authors:  L Morlé; A F Roux; N Alloisio; B Pothier; J Starck; L Denoroy; F Morlé; R C Rudigoz; B G Forget; J Delaunay
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

5.  Improvements in protein secondary structure prediction by an enhanced neural network.

Authors:  D G Kneller; F E Cohen; R Langridge
Journal:  J Mol Biol       Date:  1990-07-05       Impact factor: 5.469

6.  Full-length sequence of the cDNA for human erythroid beta-spectrin.

Authors:  J C Winkelmann; J G Chang; W T Tse; A L Scarpa; V T Marchesi; B G Forget
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

7.  A theorem on amplitudes of thermal atomic fluctuations in large molecules assuming specific conformations calculated by normal mode analysis.

Authors:  N Go
Journal:  Biophys Chem       Date:  1990-01       Impact factor: 2.352

8.  Structure of human erythrocyte spectrin. I. Isolation of the alpha-I domain and its cyanogen bromide peptides.

Authors:  D W Speicher; G Davis; P D Yurchenco; V T Marchesi
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

9.  A structural model of human erythrocyte spectrin. Alignment of chemical and functional domains.

Authors:  D W Speicher; J S Morrow; W J Knowles; V T Marchesi
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

10.  The molecular structure of human erythrocyte spectrin. Biophysical and electron microscopic studies.

Authors:  D M Shotton; B E Burke; D Branton
Journal:  J Mol Biol       Date:  1979-06-25       Impact factor: 5.469

View more
  1 in total

1.  Conformational changes at the tetramerization site of erythroid alpha-spectrin upon binding beta-spectrin: a spin label EPR study.

Authors:  Chloe Antoniou; Vinh Q Lam; L W-M Fung
Journal:  Biochemistry       Date:  2008-09-11       Impact factor: 3.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.